Asset Details
Do you wish to reserve the book?
Iatrogenic cardiac perforation following pacemaker and defibrillator implantation; presentation, management and outcomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Iatrogenic cardiac perforation following pacemaker and defibrillator implantation; presentation, management and outcomes
Do you wish to request the book?
Iatrogenic cardiac perforation following pacemaker and defibrillator implantation; presentation, management and outcomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Iatrogenic cardiac perforation following pacemaker and defibrillator implantation; presentation, management and outcomes
2020
Overview
Aims: Cardiac perforations caused by pacemaker and implantable-cardioverter defibrillator (ICD) leads are serious events. Due in part to their infrequency, management options and outcomes are unclear. Methods: A single-centre retrospective study was conducted at a high-volume tertiary centre to identify patients in whom cardiac perforation occurred due to lead implantation or intervention. The search included all lead procedures spanning 3 years from 2016-2019. 6 months follow-up was assessed in all patients with perforation. Results: Of 4619 procedures 32 patients were diagnosed with lead related cardiac perforation (involving 33 leads), mean age 74±15 years, 20 (63%) female, mean left ventricular ejection fraction 51% (±11). 9 devices were implanted at other centres; therefore, the institutional rate of perforation was 0.5% (n=23 patients, 24 leads). 9 (39%) were identified acutely (<24 hours), median time to diagnosis was 32 (±49) days in sub-acute/chronic perforation. All but one leads were active fixation models; 25/32 (78%) had abnormal electrical parameters at device interrogation. 6/33 (18%) were ICD leads. 27/33 (82%) leads perforated the right ventricle (RV) in the apex or anterior apical region, 3 (9%) mid anterior RV and 2 (6%) lateral right atrium. Management was trans-venous in 31/32 (97%) patients with lead extraction or repositioning; pericardial drainage was required in 10/32 (31%), sternotomy with surgical repair was required in 1 (3%). 1 (3%) patient was deceased within 30 days, all other patients made a full recovery and were well at 6 months follow-up. Conclusion: Although infrequent (0.5%), perforation occurred predominantly in the RV apex. No clear patient factors were identified as risk factors. Trans-venous lead extraction was safe and effective with surgical intervention rarely required.
Publisher
Touch Medical Media Limited
Subject
